Latest filing published 15 Nov 2021 for MEDIFAST INC, €67k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kevin G. Byrnes, listed as board member, appears in our data through filings on Medifast Inc shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 4 February 2016 to 11 November 2021.
The open-market record consists of 1 sale worth €128k, with no purchase. The rest of the record consists of 2 share grants and 1 option exercise. Since January 2021: no purchases and 1 sale on the market.
On 15 November 2021 came the latest disclosure, an option exercise for €67k in Medifast Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations